To what we know Dr Pestell didn't recognized very important phenomena in cancers treatment , patients even with lover ccr5 on the tumor cells but higher CCR5 on the macrophages surrounding tumors should do very well with Leronlimab treatment .

This is why our very first emergency patient was refused treatment , even when dr Patterson was asking them to continue ,
This observation was due to Dr Patterson research and conclusion , I believe that we are very lucky to have him working with us ..

This is a very big difference to every patient with metastatic cancers ...



IMO as always .